Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

STRATIFYHF

Financiado

Cerrado

Artificial intelligence-based decision support system for risk stratification an...

Artificial intelligence-based decision support system for risk stratification and early detection of heart failure in primary and secondary care Heart failure (HF) is a pandemic currently affecting up to 15 million people in Europe. It is a complex clinical syndrome presenting with impaired heart function and is associated with poor quality of life for patients and high he... ver más

31/05/2027

ISTRAZIVACKO RAZVO...

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

ISTRAZIVACKO RAZVOJNI CENTAR ZA BIOINZENJERIN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-06-01

HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage: Prevention of obesity throughout th... ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or...

I+D

Cerrada hace 2 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

ISTRAZIVACKO RAZVOJNI CENTAR...

Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

INVESTIGACIÓN Y DESARROLLO DE NUEVAS TECNOLOG... INVESTIGACIÓN Y DESARROLLO DE NUEVAS TECNOLOGÍAS ELECTROMÉDI... 445K€ Cerrado

SCAUT DECISIO Preventive and Personalised Remote Care for Heart Patients 3M€ Cerrado

AI-driven cardiac ultrasound analysis AI-driven cardiac ultrasound analysis 4M€ Cerrado

CoronAI AI software for the automated detection of covid 19 infectio... 3M€ Cerrado

TED2021-132879B-I00 PLATAFORMA DE IA-CARDIOLOGIA DE MONITORIZACION AVANZADA BASA... 305K€ Cerrado

COPCAR Heart monitoring and early assistance in high risk crisis wi... 71K€ Cerrado

Duración del proyecto: 47 meses Fecha Inicio: 2023-06-01
Fecha Fin: 2027-05-31

Líder del proyecto

ISTRAZIVACKO RAZVOJNI CENTAR ZA BIOINZENJERIN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Heart failure (HF) is a pandemic currently affecting up to 15 million people in Europe. It is a complex clinical syndrome presenting with impaired heart function and is associated with poor quality of life for patients and high healthcare costs. There is a high clinical demand for novel artificial intelligence (AI) tools which will facilitate risk stratification, early diagnosis, and disease progression assessment in HF. Such tools are essential to allow prompt initiation of evidence-based prevention and treatment strategies which will improve patient quality of life, reduce morbidity and mortality and the HF burden on healthcare. STRATIFYHF aims to develop, validate and implement the first AI-based, decision support system (DSS) for risk stratification, early diagnosis, and disease progression assessment in HF to accommodate both primary and secondary care clinical needs. The DSS will integrate patient-specific demographic and clinical data using existing and novel technologies and establish AI-based tools for risk stratification and HF prediction using machine learning. Additionally, a mobile app will be developed to empower patients to better manage their condition, and health care professionals to make informed decision in selection of evidence-based HF prevention and treatment strategies. Our multidisciplinary consortium, including three small-to-medium enterprises (SMEs) and two stakeholder organisations, will be guided by medical advice and regulatory and health technology experts to deliver the DSS as a medical class 2b device, reaching TRL 8 by the end of the project. STARTIFYHF will change the way in which HF is diagnosed today and thereby improve the quality and length of patients’ lives and lead to efficient and sustainable healthcare systems by reducing the number of HF-related hospital admissions and unnecessary referrals from primary to secondary care in Europe and beyond.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores